From Trace Alkaloid to Schedule I Target: The Kratom and 7-OH Story
Regulatory & Scientific Insight From Trace Alkaloid to Schedule I: The Kratom and 7-OH Story Dr. Patience Fowoyo, PhD Fowoyo Scientific Consulting July 7, 2026 11 min read The Kratom & 7-OH Story How a molecule barely present in the kratom leaf was concentrated far beyond natural levels, sold in everyday consumer products, and is […]
The Evidentiary Standard That Is Reshaping Scientific Claims
Scientific Insights Regulatory Science The Evidentiary Standard That Is Reshaping Scientific Claims As regulatory bodies and market gatekeepers apply greater scrutiny to the evidence behind product claims, the gap between what businesses assert and what science can genuinely support has become a source of commercial and legal risk. Author Patience Fowoyo, PhD Published June 2025 […]
Structure/Function Claims Under DSHEA: What’s Allowed, What’s Not, and Why It Matters
The line between an allowed structure/function claim and an implied disease claim is thinner than it looks — and crossing it has real consequences.
Why Most Supplement Claims Won’t Survive FDA Scrutiny — And What to Do About It
The gap between popular supplement claims and scientifically substantiated ones is wider than most brands realize. Here is what the evidence actually requires.